Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.7)
Index Copernicus  – 161.11; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 11, November, p. 1477–1482

doi: 10.17219/acem/93728

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Adipose tissue miRNA level variation through conjugated linoleic acid supplementation in diet-induced obese rats

Maryam Nazari1,A,B,D, Alihossein Saberi2,E,F, Majid Karandish3,C,E, Mohammad Taha Jalali4,C,F

1 Food (Salt) Safety Research Center, School of Nutrition and Food Sciences, Semnan University of Medical Sciences, Iran

2 Department of Medical Genetics, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Iran

3 Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Iran

4 Hyperlipidemia Research Center, Ahvaz Jundishapur University of Medical Sciences, Iran

Abstract

Background. Conjugated linoleic acid (CLA), which is an octadecadienoic acid isomer, is believed to play different positive physiological roles, such as lowering body fat. Due to some reported side effects of CLA, like lipodystrophy and impaired glucose metabolism, it is important to establish its safety by understanding detailed molecular mechanisms. One of these mechanisms may be the role of this dietary agent in modifying the function and activity of microRNAs (miRNAs).
Objectives. The aim of the study was to investigate how adipocyte miR-27a and miR-143 expression may be influenced by CLA in obese rats.
Material and Methods. In this study, 24 male Wistar rats were randomly divided into normal-fat diet (NFD) and high-fat diet (HFD) groups. After 8 weeks, the rats were weighed and half of the diet-induced obese rats were randomly selected to receive 500 mg CLA per 1 kg body weight for 4 weeks. At the end of this period, epididymal fat was isolated to investigate the expression level of miRNAs by real-time polymerase chain reaction (RT-PCR).
Results. After 12 weeks, the obese rats in the HFD group, compared with rats in the NFD group, demonstrated a significant decrease in the expression of miR-27a (p < 0.05) and a significant increase in the expression of miR-143 (p < 0.05). In the group which had received CLA for a 4-week period, these events were reversed. Moreover, the rats in this group gained less weight than other rats in HFD groups, although the difference was not statistically significant.
Conclusion. In conclusion, this study demonstrated that CLA, as an anti-obesity agent, may minimize abnormal changes in miRNA expression in obesity. This suggests a new pathway for weight loss; however, further studies are needed.

Key words

obesity, microRNA, high-fat diet, conjugated linoleic acid

References (30)

  1. Padula WV, Allen RR, Nair KV. Determining the cost of obesity and its common comorbidities from a commercial claims database. Clin Obes. 2014;4(1):53–58.
  2. Alexander R, Lodish H, Sun L. MicroRNAs in adipogenesis and as therapeutic targets for obesity. Expert Opin Ther Targets. 2011;15(5):623–636.
  3. Kumar P, Bhandari U. Letter to the editor: Obesity Pharmacotherapy: Current Status. EXCLI J. 2015;14:290–293.
  4. Ortega FJ, Moreno-Navarrete JM, Pardo G, et al. MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLOS ONE. 2010;5(2):e9022.
  5. Xie H, Sun L, Lodish HF. Targeting microRNAs in obesity. Expert Opin Ther Targets. 2009;13(10):1227–1238.
  6. Arner P, Kulyté A. MicroRNA regulatory networks in human adipose tissue and obesity. Nat Rev Endocrinol. 2015;11(5):276–288.
  7. García-Segura L, Pérez-Andrade M, Miranda-Ríos J. The emerging role of microRNAs in the regulation of gene expression by nutrients. J Nutrigenet Nutrigenomics. 2013;6(1):16–31.
  8. Chartoumpekis DV, Zaravinos A, Ziros PG, et al. Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLOS One. 2012;7(4):e34872.
  9. Romao JM, Jin W, He M, McAllister T, Guan LL. Altered microRNA expression in bovine subcutaneous and visceral adipose tissues from cattle under different diet. PLOS One. 2012;7(7):e40605. doi:10.1371/journal.pone.0040605.
  10. Williams MD, Mitchell GM. MicroRNAs in insulin resistance and obesity. Exp Diabetes Res. 2012;2012:484696. doi:10.1155/2012/484696.
  11. McCann SE, Liu S, Wang D, et al. Reduction of dietary glycaemic load modifies the expression of microRNA potentially associated with energy balance and cancer pathways in pre-menopausal women. Br J Nutr. 2013;109(4):585–592.
  12. Keller J, Ringseis R, Eder K. Supplemental carnitine affects the microRNA expression profile in skeletal muscle of obese Zucker rats. BMC Genomics. 2014;15(1):512. doi:10.1186/1471-2164-15-512.
  13. Jeukendrup AE, Randell R. Fat burners: Nutrition supplements that increase fat metabolism. Obes Rev. 2011;12(10):841–851.
  14. Lehnen TE, Ramos M, Camacho A, Marcadenti A, Lehnen AM. A review on effects of conjugated linoleic fatty acid (CLA) upon body composition and energetic metabolism. J Int Soc Sports Nutr. 2015. doi:10.1186/s12970-015-0097-4.
  15. Silveira M-B, Carraro R, Monereo S, Tébar J. Conjugated linoleic acid (CLA) and obesity. Public Health Nutr. 2007;10(10A):1181–1186.
  16. Sacco J, Adeli K. MicroRNAs: Emerging roles in lipid and lipoprotein metabolism. Curr Opin Lipidol. 2012;23(3):220–225.
  17. Takanabe R, Ono K, Abe Y, et al. Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem Biophys Res Commun. 2008;376(4):728–732.
  18. Kim SY, Kim Y, Lee HW, et al. miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARγ expression. Biochem Biophys Res Commun. 2010;392(3):323–328.
  19. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123(11):1939–1951.
  20. LaRosa PC, Miner J, Xia Y, Zhou Y, Kachman S, Fromm ME. Trans-10, cis-12 conjugated linoleic acid causes inflammation and delipidation of white adipose tissue in mice: A microarray and histological analysis. Physiol Genomics. 2006;27(3):282–294.
  21. Woods SC, Seeley RJ, Rushing PA, D’Alessio D, Tso P. A controlled high-fat diet induces an obese syndrome in rats. J Nutr. 2003;133(4):1081–1087.
  22. Chopra RJ. Synergistic conjucated linoleic acid (CLA) and carnitine combination. Pat Appl Publ. 2006;23:1–13.
  23. Kopelman PG, Caterson ID. An overview of obesity management. In: Kopelman PG, Caterson ID, Dietz WH, eds. Clinical Obesity in Adults and Children. 3rd ed. Hoboken, USA: Wiley-Blackwell; 2010:267–274.
  24. Diniz YS, Santos PP, Assalin HB, et al. Conjugated linoleic acid and cardiac health: Oxidative stress and energetic metabolism in standard and sucrose-rich diets. Eur J Pharmacol. 2008;579(1–3):318–325.
  25. Visscher TLS, Snijder MB, Seidell JC. Epidemiology: Definition and classification of obesity. In: Kopelman PG, Caterson ID, Dietz WH, eds. Clinical Obesity in Adults and Children. 3rd ed. Hoboken, USA: Wiley-Blackwell; 2010:3–14.
  26. Warden CH, Fisler JS. Comparisons of diets used in animal models of high fat feeding. Cell Metab. 2009;7(4):277.
  27. Parra P, Serra F, Palou A. Expression of adipose microRNAs is sensitive to dietary conjugated linoleic acid treatment in mice. PLOS ONE. 2010;5(9):e13005. doi:10.1371/journal.pone.0013005.
  28. Esau C, Kang X, Peralta E, et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem. 2004;279(50):52361–52365.
  29. Lin Q, Gao Z, Alarcon RM, Ye J, Yun Z. A role of miR-27 in the regulation of adipogenesis. FEBS J. 2009;276(8):2348–2358.
  30. McGregor R, Choi M. microRNAs in the regulation of adipogenesis and obesity. Curr Mol Med. 2011;11(4):304–316.
© Wroclaw Medical University